×
About 583 results

ALLMedicine™ Localized Scleroderma Center

Research & Reviews  196 results

Linear Scleroderma Causing Arrest of Root Development in a Pediatric Patient.
https://www.ncbi.nlm.nih.gov/pubmed/35337396
Journal of Dentistry for Children (Chicago, Ill.); Chua JMC, Fei Yeo J et. al.

Mar 27th, 2022 - Localized scleroderma (LoS) or morphea is a rare group of inflammatory disorders resulting in excessive collagen deposition and subsequent sclerosis of the skin and subdermal tissues. Linear scleroderma (LiS) or linear morphea is the most common s...

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
https://clinicaltrials.gov/ct2/show/NCT01808937

Mar 2nd, 2022 - The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: How mor...

Combination of Autologous Fat Grafting and Negative-Pressure Wound Therapy for the Trea...
https://doi.org/10.1097/SCS.0000000000008355
The Journal of Craniofacial Surgery; Chicco M, Ahmadi AR et. al.

Nov 12th, 2021 - Scalp linear scleroderma (LSc) is a subtype of localized scleroderma which typically affects young patients and which can be severely disfiguring. Traditional treatment options include bone grafting or tissue expansion. In this report, we present ...

Flap Reconstruction for Treatment of Pediatric Linear Scleroderma.
https://doi.org/10.1097/SAP.0000000000002887
Annals of Plastic Surgery; Yan M, Stans AA et. al.

Oct 27th, 2021 - Linear scleroderma is a rare connective tissue disease characterized by thickening of the skin due to excess collagen deposit. It is the most frequent type of localized scleroderma in the pediatric population (40%-70%), and it usually affects the ...

see more →

Clinicaltrials.gov  7 results

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
https://clinicaltrials.gov/ct2/show/NCT01808937

Mar 2nd, 2022 - The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: How mor...

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
https://clinicaltrials.gov/ct2/show/NCT04200755

Oct 18th, 2021 - Localized scleroderma (LS) comprises a heterogenous group of sclerotic skin disorders. The incidence of LS is reported to be approximately 27 cases/ 1x106 and is hence approximately 2-3-fold higher compared to systemic scleroderma. Although in mos...

The Influence of Extracorporeal Photopheresis on Skin Sclerosis
https://clinicaltrials.gov/ct2/show/NCT04752397

Feb 16th, 2021 - Background and Rationale: Extracorporeal photopheresis: In this immunomodulatory therapy, the apheresis leukocytes of the patients are irradiated with ultraviolet (UV) A in the presence of a photosensitizing agent, 8-methoxypsoralen prior to reinf...

Genetic Variants in Linear Localized Scleroderma
https://clinicaltrials.gov/ct2/show/NCT02222038

Nov 10th, 2020 - At present the etiology of LLS is unknown, but a genetic background is suspected. Although LLS clearly classifies as a mosaic disorder, its genetics and protein machinery remain to be understood. We are going to use a tailored approach to identify...

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
https://clinicaltrials.gov/ct2/show/NCT00230373

Apr 23rd, 2015 - Localized scleroderma or morphea is a fibrotic disease, imiquimod induces cytokines which inhibit fibrotic activity . We propose that topical imiquimod 5% cream is efficacious and safe in treating plaque-type morphea. Twenty adults will be enrolle...

see more →

News  26 results

Morphea Often Follows Relapsing-Remitting Course
https://www.medscape.com/viewarticle/928435

Apr 10th, 2020 - NEW YORK (Reuters Health) - Morphea, or localized scleroderma, often follows a relapsing-remitting course over several years, but existing treatment plans appear to improve disease activity and stabilize disease damage, researchers report. Morphea...

Idiopathic Bilateral Auricular Ossificans
https://www.mdedge.com/dermatology/article/206973/mixed-topics/idiopathic-bilateral-auricular-ossificans
David B. Harker, MD, Andrew P. Word, MD et. al.

Aug 26th, 2019 - To the Editor: A 60-year-old man with a history of basal cell carcinoma, rosacea, and seborrheic dermatitis presented for a routine skin examination. The patient mentioned incidentally that both of his ears were “rock hard” and had been so for the.

Booster vaccines found largely safe in children on immunosuppressive drugs
https://www.mdedge.com/rheumatology/article/202986/pediatrics/booster-vaccines-found-largely-safe-children
Ted Bosworth

Jun 16th, 2019 - MADRID – Administration of live attenuated booster of the MMR vaccine with or without varicella (MMR/V) was not associated with serious adverse events in children on immunosuppressive therapy for a rheumatic disease, according to data presented at.

Tackling the challenges of pediatric localized scleroderma
https://www.mdedge.com/rheumatology/article/198330/lupus-connective-tissue-diseases/tackling-challenges-pediatric-localized/page/0/1?channel=39313

Apr 5th, 2019 - In the randomized trial of first-line methotrexate, 48 of 65 patients treated with methotrexate plus steroid (74%) were responders. And among those 48 responders, 35 (73%) maintained a clinical remission for a mean of 25 months off-drug, while ano.

Tackling the challenges of pediatric localized scleroderma
https://www.mdedge.com/rheumatology/article/198330/lupus-connective-tissue-diseases/tackling-challenges-pediatric-localized
Bruce Jancin

Apr 5th, 2019 - MAUI, HAWAII – One of the most important steps to take when a child has received a biopsy-confirmed diagnosis of localized scleroderma is to sit down with the family and explain the rationale for the aggressive therapies to come, Anne M. Stevens,.

see more →

Patient Education  4 results see all →